Cosmetic Safety Enhancement Act of 2019

Summary

Cosmetic Safety Enhancement Act of 2019 This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 3 December 2019

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 3 December 2019

   Introduced

   Introduced in House

   Source: IntroReferral

3. 3 December 2019

   Introduced

   Introduced in House

   Source: IntroReferral

4. 4 December 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 11 March 2020

   Committee

   Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

   Source: Committee

6. 11 March 2020

   Committee

   Subcommittee Consideration and Mark-up Session Held.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 3 December 2019 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 3 December 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 3 December 2019

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 3 December 2019

  Open at official source

Sponsors

• Rep. Pallone, Frank [D-NJ-6] · D · Sponsor
• · hsif00 · Standing

Related records

• related to → Personal Care Products Safety Act